About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multicenter Hologic Tomosynthesis Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00971087

Multicenter Hologic Tomosynthesis Study

The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Syntheti...

Lead sponsor: Hologic, Inc.•22 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hologic, Inc.

Age

18 - 110 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Female
•Any ethnic origin
•No contraindication of routine bilateral mammography

Exclusion Criteria

•Any contraindications to mammographic screening, including but not limited to:
•Significant existing breast trauma
•Pregnancy
•Lactating
•Previous surgical biopsy
•Previous breast cancer
•Placement of an internal breast marker
•Breast implants
•Unable to understand and execute written informed consent
•Breasts are too large to be imaged on the 24 cm by 29 cm detector with a single exposure

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878 · Advanced Breast Cancer

RECRUITINGPhase 2

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998 · Breast Cancer

RECRUITINGPhase 4

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

RECRUITINGPhase 2

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 26, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment3,521

Start dateSep 2009

Last updatedFeb 26, 2025

Condition

Locations shown

Scottsdale Medical Imaging Ltd. (SMIL)

Scottsdale, Arizona

Hoag Memorial Hospital

Newport Beach, California

UC Davis

Sacramento, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 26, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions